The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adults.
CALM
Ingestion of a Novel Algae Protein Source on Rested and Post Exercise Muscle Protein Synthesis Rates.
1 other identifier
interventional
15
1 country
1
Brief Summary
To assess the rested and postexercise muscle protein synthetic response following the ingestion of a flavourless algae protein source compared with whey protein in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2025
CompletedFirst Submitted
Initial submission to the registry
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFebruary 28, 2025
February 1, 2025
9 months
February 24, 2025
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial muscle protein synthesis
unilateral exercise followed by protein ingestion (algae / whey)
4 hours
Study Arms (2)
Whey protein
ACTIVE COMPARATORAlgae protein
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Males and Females BMI 18.5 - 30 kg/m2 Aged 65-80 years Recreationally Active
You may not qualify if:
- Body mass index (BMI) \<18.5 or \>30 kg/m2 Any metabolic impairments Any cardiovascular impairments High blood pressure (≥140/90 mmHg) Any gastrointestinal disorders Any medications known to affect protein and/or amino acid metabolism A personal or family history of epilepsy, seizures or schizophrenia, motor disorder Chronic over the counter use of pharmaceuticals (\> 1 month) Allergic to any of the whole foods included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health and Life Sciences
Exeter, EX2 8BD, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Research Associate
Study Record Dates
First Submitted
February 24, 2025
First Posted
February 28, 2025
Study Start
February 23, 2025
Primary Completion
December 1, 2025
Study Completion
March 1, 2026
Last Updated
February 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share